Sunday, September 13, 2026
spot_img

NNIT A/S: NNIT shares its financial calendar for 2026

The financial calendar for 2026:

28 January 2026 Deadline for shareholder proposals for the Annual General Meeting
5 February 2026 Interim Financial Report Q4 2025 and Annual Report 2025
12 March 2026 Annual General Meeting
12 May 2026 Interim Financial Report Q1 2026
27 August 2026 Interim Financial Report H1 2026
5 November 2026 Interim Financial Report Q3 2026

For more information, please contact:

Investor Relations
Carsten Ringius
EVP & CFO
Tel: +45 3077 8888
[email protected]

Media Relations
Thomas Stensbøl
Press & Communications Manager
Tel: +45 3077 8800
[email protected]

ABOUT NNIT

NNIT is a leading provider of IT solutions to life sciences internationally, and to the public and private sectors in Denmark. 

We focus on high complexity industries and thrive in environments where regulatory demands and complexity are high. 

We advise on and build sustainable digital solutions that work for the patients, citizens, employees, end users or customers. 

We strive to build unmatched excellence in the industries we serve, and we use our domain expertise to represent a business first approach – strongly supported by a selection of partner technologies but always driven by business needs rather than technology. 

NNIT consists of group company NNIT A/S and the subsidiary SCALES. Together, these companies employ around 1,600 people in Europe, Asia and the USA.

Attachment

  • NNIT_Company Announcement_Financial calendar 2026

Powered by SlickText.com

Hot this week

Capgemini signs a definitive agreement to sell Capgemini Government Solutions

Media RelationsSam ConnattyTel.: +44 (0) 7811 486517E-Mail: [email protected] ...

Michelin | Disclosure of the total number of voting rights and of the number of shares making up the company’s capital

Clermont-Ferrand, September 11th, 2026 COMPAGNIE GÉNÉRALE DES...

Clearmind Enrolls First Patients with Alcohol Use Disorder in CMND-100 Clinical Trial

Vancouver, Canada, Sept. 11, 2026 (GLOBE NEWSWIRE) --...

Allarity Therapeutics Announces Strategic Capital Allocation for Filing of SPAC Registration Statement

  TARPON SPRINGS, Fla., September 11, 2026 –...

Topics

spot_img

Related Articles

Popular Categories

spot_img